Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea

Conditions:   Ischemic Heart Disease;   Acute Myocardial Infarction Interventions:   Biological: Stage 1-Low dose VM202;   Biological: Stage 1-Middle dose VM202;   Biological: Stage 1-High dose VM202;   Drug: Stage 2-Placebo;   Biological: Stage 2-Low dose VM202;   Biological: Stage 2-High dose VM202;   Device: C-Cathez® Catheter Sponsor:   ViroMed Co., Ltd. dba VM BioPharma Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials